Adapter Aids Positioning of Syringes in Autoinjectors - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Adapter Aids Positioning of Syringes in Autoinjectors

Equipment and Processing Report

Gerresheimer's patent-pending Gx G-Fix adapter integrates prefilled glass syringes with polymer-based autoinjector devices. Most autoinjectors contain two main modules: the injector itself and the prefilled syringe. The modules are combined in one assembly, but combining two different materials is a challenge, because glass prefilled syringes have different tolerance requirements than plastic devices. The plastic adapter attaches to the syringe shoulder and provides a precisely defined interface to the device.

In the past, the high dimensional tolerance of the glass syringe only permitted limited control of the injection needle’s position in the front opening of the autoinjector. Because Gx G-Fix is specifically adapted to the autoinjector, it allows accurate needle positioning and improves control of the injection process. The adapter also protects the syringe against breakage. Conventional products coupled the syringe with the finger flange. When triggered, the structurally sensitive flange is subjected to a lot of pressure and can easily break. With Gx G-Fix, however, attaching the syringe at the sturdier shoulder minimizes the risk of breakage.

The Gx G-Fix is assembled in conjunction with ready-to-fill syringe processing at the syringe manufacturer’s facility. Device integration and RNS positioning with Gx G-Fix can be used individually or in combination in the autoinjector. Plastic syringes can also be easily fitted with the adapter. Autoinjectors with Gx G-Fix are therefore suitable for both plastic and glass syringes and can be used for a variety of drugs. No changes to the customer’s filling station are necessary.

Source: Gerresheimer

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Equipment and Processing Report,
Click here